The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
Kenneth J. Smith, MD, MS, from the University of Pittsburgh, responds to our questions about his research on a potential universal flu vaccine for older adults.
